Who backs Pheast Therapeutics?
4 investors| Investor | Type |
|---|---|
| Alexandria Venture Investments | Other |
| ARCH Venture Partners | Venture capital |
| Catalio Capital Management | Venture capital |
| Rsquared | Venture capital |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Pheast Therapeutics investors
4 investors are on record for Pheast Therapeutics, including Alexandria Venture Investments, ARCH Venture Partners, Catalio Capital Management and Rsquared. The early-stage round in Oct 2025 drew 7 investors.
Free account
More of Pheast Therapeutics with a free account
- ·Watch Pheast Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 4 firms already write checks for companies like Pheast Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View